← Leaderboards
D. Wade Gibson
Johns Hopkins University
$11,156,534
Attributed
$11,156,534
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$11,156,534 · 8
By mechanism
T32$5,093,648 · 1
R01$3,795,476 · 2
R21$1,857,410 · 4
R56$410,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ravit Boger$5,491,372
- Cynthia Wolberger$11,583,176
- Irving M Reti$3,584,604
- James E.k Hildreth$35,159,425
- Zhaohao Liao$635,990
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusVirus ReplicationHerpesviridaeAntiviral AgentsCapsidProtein Structure FunctionProteinsTissue /Cell CultureMutantBiologicalPeptide HydrolasesInfectionVirusCellsBaseVirus ProteinPilot ProjectsSiteVirionInhibitor/AntagonistSuccessMemberBiochemicalResearch Study
Grant awards (35)
Herpesvirus Deubiquitylase: Virion Substrates and Autocatalytic Activity$324,000
R21 · FY2015 · AI · contact PI
Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly$228,420
R21 · FY2013 · AI · contact PI
Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function$205,000
R21 · FY2012 · AI · contact PI
Establish and Apply In Vitro System for Human Cytomegalovirus Capsid Assembly$202,500
R21 · FY2012 · AI · contact PI
Cytomegalovirus UL80 Proteins:Interactions and Modifications that Impact Function$246,000
R21 · FY2011 · AI · contact PI
Training in Anti-Cancer Drug Development$534,871
T32 · FY2010 · CA · contact PI
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors$243,540
R21 · FY2010 · AI · contact PI
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors$202,950
R21 · FY2010 · AI · contact PI
Training in Anti-Cancer Drug Development$524,064
T32 · FY2009 · CA · contact PI
Cytomegalovirus Deubiquitinase pUL48: Identifying Substrate and Inhibitors$205,000
R21 · FY2009 · AI · contact PI
Training in Anti-Cancer Drug Development$511,755
T32 · FY2008 · CA · contact PI
Herpesvirus Protein Synthesis And Virion Assembly$410,000
R56 · FY2008 · AI · contact PI
Training in Anti-Cancer Drug Development$515,336
T32 · FY2007 · CA · contact PI
Herpesvirus Proteinase - Possible Target for Antivirals$271,299
R01 · FY2007 · AI · contact PI
Training in Anti-Cancer Drug Development$500,731
T32 · FY2006 · CA · contact PI
Herpesvirus Proteinase - Possible Target for Antivirals$279,402
R01 · FY2006 · AI · contact PI
Training in Anti-Cancer Drug Development$511,992
T32 · FY2005 · CA
Herpesvirus Protein Synthesis and Virion Assembly$367,875
R01 · FY2005 · AI
Herpesvirus Proteinase - Possible Target for Antivirals$286,125
R01 · FY2005 · AI
Training in Anti-Cancer Drug Development$453,650
T32 · FY2004 · CA
Herpesvirus Protein Synthesis and Virion Assembly$367,875
R01 · FY2004 · AI
Herpesvirus Proteinase - Possible Target for Antivirals$286,125
R01 · FY2004 · AI
Training in Anti-Cancer Drug Development$47,412
T32 · FY2004 · CA
Training in Anti-Cancer Drug Development$425,081
T32 · FY2003 · CA
Herpesvirus Protein Synthesis and Virion Assembly$367,875
R01 · FY2003 · AI
Herpesvirus Proteinase - Possible Target for Antivirals$127,188
R01 · FY2003 · AI
TRAINING IN ANTI-CANCER DRUG DEVELOPMENT$440,262
T32 · FY2002 · CA
Herpesvirus Protein Synthesis and Virion Assembly$367,875
R01 · FY2002 · AI
TRAINING IN ANTI-CANCER DRUG DEVELOPMENT$41,088
T32 · FY2002 · CA
TRAINING IN ANTI-CANCER DRUG DEVELOPMENT$369,449
T32 · FY2001 · CA
Herpesvirus Protein Synthesis and Virion Assembly$313,739
R01 · FY2001 · AI
HERPESVIRUS PROTEINASE--POSSIBLE TARGET FOR ANTIVIRALS$206,029
R01 · FY2001 · AI
HERPESVIRUS PROTEIN SYNTHESIS AND VIRION ASSEMBLY$354,693
R01 · FY2000 · AI
TRAINING IN ANTI-CANCER DRUG DEVELOPMENT$217,957
T32 · FY2000 · CA
HERPESVIRUS PROTEINASE--POSSIBLE TARGET FOR ANTIVIRALS$199,376
R01 · FY2000 · AI